Grifols sCD38
Anti-daratumumab antibody · class II · Valid
- Registration no.
- 80134860308
- Process no.
- 25351458325202412
- Status
- Valid
- Device type
- Anti-daratumumab antibody (ANTICORPO ANTI-DARATUMUMAB)
- Risk class
- II
- Registration holder
- GRIFOLS BRASIL LTDA CNPJ 02.513.899/0001-71 · 342 registrations
- Manufacturer
- Published
- 17/02/2025
- Valid until
- No expiry (VIGENTE)
- Last updated by ANVISA
- 2026-10-12
- Official record
- View on ANVISA ↗